While the oncogenic role of IGFBP2 has been established in various tumor types, including breast, ovarian, glioma and prostate tumors [13, 14, 26], its specific mechanisms and involvement in HCC have remained elusive. This evidence concerns the gene IGFBP2 and glioma.